Research output per year
Research output per year
Personal profile
Headline
PROFESSOR
Biography
Fingerprint
Dive into the research topics where Jean-Frédéric Colombel is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
Shang, J., Del Valle, D. M., Britton, G. J., Mead, K. R., Rajpal, U., Chen-Liaw, A., Mogno, I., Li, Z., Menon, R., Gonzalez-Kozlova, E., Elkrief, A., Peled, J. U., Gonsalves, T. R., Shah, N. J., Postow, M., Colombel, J. F., Gnjatic, S., Faleck, D. M. & Faith, J. J., 6 Jan 2025, In: Journal of Experimental Medicine. 222, 1Research output: Contribution to journal › Article › peer-review
Open Access -
Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn's Disease
Feagan, B. G., Colombel, J. F., Panaccione, R., Schreiber, S., Ferrante, M., Kamikozuru, K., Ma, C., Lee, W. J., Griffith, J., Joshi, N., Kligys, K., Kalabic, J., Xuan, S. & Dubinsky, M., Jan 2025, In: Gastro Hep Advances. 4, 1, 100544.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials
Colombel, J. F., Lacerda, A. P., Irving, P. M., Panaccione, R., Reinisch, W., Rieder, F., Steinlauf, A., Schwartz, D., Feng, T., Dubcenco, E., Anyanwu, S. I., Laroux, F. S., Cunneen, C. & Powell, N., 2025, (Accepted/In press) In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Natural History of Clinically Suspected Isolated Perianal Fistulizing Crohn's Disease
Sangmo, L., Quraishi, B., Rajauria, P., Giselbrecht, E., Colombel, J. F., Ungaro, R. & Wong, S. Y., 2025, (Accepted/In press) In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Short survey › peer-review
-
Prior Anti-TNF Exposure Is Associated with an Increased Risk of Short- and Long-Term Colectomy in Acute Severe Ulcerative Colitis
Bourgonje, A. R., Posner, H., Carbonnel, F., Colombel, J. F. & Kayal, M., 2025, (Accepted/In press) In: Digestive Diseases and Sciences.Research output: Contribution to journal › Article › peer-review
Press/Media
-
US FDA approves Celltrion’s Zymfentra for treatment of people with inflammatory bowel disease
25/10/23
1 item of Media coverage
Press/Media
-
US FDA approves Celltrion's Zymfentra for treatment of people with inflammatory bowel disease
25/10/23
1 item of Media coverage
Press/Media
-
-
Celltrion USA Announces U.S. FDA Approval of ZYMFENTRA® (infliximab-dyyb), the First and Only Subcutaneous infliximab, for the Treatment of People With Inflammatory Bowel Disease
22/10/23 → 23/10/23
10 items of Media coverage
Press/Media
-
FDA approves Zymfentra as first subcutaneous infliximab for ulcerative colitis, Crohn’s
23/10/23
1 item of Media coverage
Press/Media